These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30449704)

  • 41. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway.
    Qureshi-Baig K; Kuhn D; Viry E; Pozdeev VI; Schmitz M; Rodriguez F; Ullmann P; Koncina E; Nurmik M; Frasquilho S; Nazarov PV; Zuegel N; Boulmont M; Karapetyan Y; Antunes L; Val D; Mittelbronn M; Janji B; Haan S; Letellier E
    Autophagy; 2020 Aug; 16(8):1436-1452. PubMed ID: 31775562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
    Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
    Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA NEAT1 regulates Hodgkin's lymphoma cell proliferation and invasion via miR-448 mediated regulation of DCLK1.
    Fan CB; Yan XH; Tian M; Zhang S; Liu JL; Sheng YX; Dong L; Zhang WL
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6219-6227. PubMed ID: 32572888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
    Das PK; Islam F; Lam AK
    Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma.
    Xu L; Wang P; Feng X; Tang J; Li L; Zheng X; Zhang J; Hu Y; Lan T; Yuan K; Zhang Y; Ren S; Hao X; Zhang M; Xu M
    Clin Sci (Lond); 2019 Oct; 133(20):2085-2105. PubMed ID: 31654063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.
    Sureban SM; May R; Weygant N; Qu D; Chandrakesan P; Bannerman-Menson E; Ali N; Pantazis P; Westphalen CB; Wang TC; Houchen CW
    Cancer Lett; 2014 Aug; 351(1):151-61. PubMed ID: 24880079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer.
    Mohammadi C; Najafi R
    J Gastrointest Cancer; 2020 Jun; 51(2):714-715. PubMed ID: 31422542
    [No Abstract]   [Full Text] [Related]  

  • 52. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases.
    Moore LL; Qu D; Sureban S; Mitchell S; Pitts K; Cooper N; Fazili J; Harty R; Oseini A; Ding K; Bronze M; Houchen CW
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.
    Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S
    Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-424 suppressed viability and invasion by targeting to the DCLK1 in neuroblastoma.
    Wan MF; Yang N; Qu NY; Pan YY; Shan YQ; Li P
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5526-5533. PubMed ID: 32495887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
    Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
    Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
    Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
    J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
    Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis.
    Zhao C; Zhao Q; Zhang C; Wang G; Yao Y; Huang X; Zhan F; Zhu Y; Shi J; Chen J; Yan F; Zhang Y
    Sci Rep; 2017 Jun; 7(1):4194. PubMed ID: 28646148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods.
    Mirzaei A; Madjd Z; Kadijani AA; Tavakoli-Yaraki M; Modarresi MH; Verdi J; Akbari A; Tavoosidana G
    Cancer Biomark; 2016 Sep; 17(3):301-311. PubMed ID: 27802206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.